Montreal, Quebec Clinical Trials

A listing of Montreal, Quebec clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

The objective of this trial is to study the efficacy of treatment of human papilloma virus (HPV) related oropharyngeal cancer with chemotherapy followed by Transoral Robotic Surgery (TORS) as definitive treatment. Current treatment of oropharyngeal cancer are chemo-radiotherapy. There is significant lifelong side effects associated with this approach related to …

primary tumor
papilloma
absolute neutrophil count
cancer
neck dissection
McGill University Health Centre
 (2.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
The TARGET-EFT Trial

Randomized clinical trial to determine whether a multicomponent intervention will lead to improvements in mobility, self-care, mood, pain, and physical activity among frail and pre-frail older adults (as measured with the Essential Frailty Toolset; EFT) hospitalized for an acute cardiovascular illness.

malnutrition
anemia
Jewish General Hospital
 (3.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

kras g12c mutation
metastatic malignant solid tumor
ki-ras
kras
solid tumor
Jewish General Hospital; Sir Mortimer B. Davis
 (0.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +7 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

combined modality therapy
docetaxel
prostate cancer
cancer
combination therapy
Centre hospitalier de l'Universit de Montr al (CHUM) Centre de Recherche
 (0.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk factors such as aging, obesity and unhealthy lifestyle. Paradoxically however, while lowering blood LDL, commonly known as "bad cholesterol", …

fish oils
body mass index
omega-3 fatty acids
type 2 diabetes mellitus
insulin sensitivity/resistance
Montreal Clinical Research Institute
 (0.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

replacement therapy
myozyme
gaa gene
deficiency
glycogen storage disease type ii
Investigational Site Number 124004
 (0.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

genetic testing
datscan
bradykinesia
tremor
resting tremor
McGill University
 (0.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. …

cell-free dna
hereditary cancer
hereditary cancer syndromes
blood test
cancer
Jewish General Hospital
 (3.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Pharmacokinetics Pharmacodynamics and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to …

acute respiratory syndrome (sars)
SARS
CHU Sainte-Justine
 (0.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +34 other locations
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

This study aims to identify and assess new CMR techniques that can improve current CMR protocols.

MRI
heart disease
respiratory system
a 10
McGill University Health Center
 (2.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location